ctDNA MRD Detection and Personalized Oncogenomic Analysis in Oligometastatic Colorectal Cancer From Plasma and Urine

We hypothesized that circulating tumor DNA (ctDNA) molecular residual disease (MRD) analysis without prior mutational knowledge could be performed after neoadjuvant chemotherapy to assess oligometastatic colorectal cancer (CRC) treated surgically with curative intent. We also investigated urine as a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JCO Precis Oncol
Main Authors: Pellini, Bruna, Pejovic, Nadja, Feng, Wenjia, Earland, Noah, Harris, Peter K., Usmani, Abul, Szymanski, Jeffrey J., Qaium, Faridi, Mudd, Jacqueline, Petty, Marvin, Jiang, Yuqiu, Singh, Ashla, Maher, Christopher A., Henke, Lauren E., Park, Haeseong, Ciorba, Matthew A., Kim, Hyun, Mutch, Matthew G., Pedersen, Katrina S., Tan, Benjamin R., Hawkins, William G., Fields, Ryan C., Chaudhuri, Aadel A.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2021
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8232837/
https://ncbi.nlm.nih.gov/pubmed/34250420
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/PO.20.00276
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados